Standard curcumin tablets have virtually zero absorption. Our LipoSone™ liquid liposomal formulation delivers 46.79× more to your bloodstream — with 30× higher plasma levels within just 2 hours.
Curcumin is poorly water-soluble and rapidly metabolized, so conventional tablets and powders fail to reach your bloodstream in usable amounts. In our head-to-head trial, the non-liposomal tablet group showed virtually no rise in serum curcumin across 6 hours. The molecule has clinical potential. The delivery is what fails.
Curcuminoids are sealed inside a sunflower-derived phosphatidylcholine bilayer — soy-free and structured to mimic your cell membranes.
The liposomal shell protects curcuminoids from stomach acid and liver metabolism — allowing them to reach systemic circulation intact.
Twenty metabolically healthy adults, randomized evenly, 250 mg curcumin daily for 6 hours (two formulations). Serum curcumin and demethoxycurcumin measured by Liquid Chromatography–Mass Spectrometry (LC/MS-MS) at hours 0, 2, 4, 6.
Both groups started at zero. Only the liposomal group rose.
A standardized complex of curcumin, demethoxycurcumin, and bisdemethoxycurcumin — the bioactive compounds found in turmeric root. We use a full-spectrum extract, not isolated curcumin alone.
The LipoSone™ delivery vehicle. Sunflower-derived, non-GMO, and free of the soy lecithin used in most liposomal supplements. Built to mimic cell membranes for efficient transport and absorption.
Convenient liquid format — no capsules, no tablets. Precise, consistent dosing with superior absorption delivered by LipoSone™.
“Das Hauptproblem bei der Curcumin-Supplementierung ist seine nahezu nicht vorhandene Wasserlöslichkeit. Alle anderen Strategien zur Verbesserung der Bioverfügbarkeit – BioPerine, Phytosomen, Nanopartikel – behandeln lediglich ein Symptom. LipoSone™ hingegen bekämpft die Ursache.”
Curcumin’s bioactive potential is only expressed when it reaches your bloodstream in meaningful quantities. Standard tablets don’t. Our liposomal form does — as measured directly in human blood plasma across a 6-hour period. This is the distinction between a supplement that’s absorbed and one that passes through.
BioPerine (piperine) temporarily increases gut permeability to improve absorption — but this mechanism has broader gastrointestinal effects. LipoSone™ uses phospholipid encapsulation that directly solubilises the hydrophobic molecule without affecting gut permeability.
250 mg per serving. 7 mL daily. 200 mL / 30-day supply. Backed by a human trial.
1Comparative oral bioavailability (incremental AUC) from a randomized, controlled human trial (n=20, 10 per group) conducted in collaboration with Surya Research Clinics, India. Measured by Liquid Chromatography–Mass Spectrometry (LC/MS-MS). These are comparative bioavailability ratios, not authorized EU health claims. Curcumin is not an authorized substance under EU Regulation 432/2012 for health claims. Individual absorption may vary. This is a food supplement and should not be used as a substitute for a varied diet and healthy lifestyle. Manufactured in Germany in compliance with Directive 2002/46/EC and EU Regulation 1169/2011. © 2026 Moana Natura · BMM Europe s.r.o.
Peak plasma curcumin was reached at the 4-hour mark in the liposomal group — with sustained elevation maintained throughout the entire 6-hour study period.
The intact curcuminoid complex arrives in circulation via LipoSone™ delivery — ready for cellular distribution and utilization.
| Parameter | LLC | TC |
|---|---|---|
| Peak serum curcumin (Cmax, µg/L) | 32.75 | 0.86 |
| Time to peak (Tmax, hours) | 4 | 4 |
| Total exposure (AUC₀–₆, ng·h/mL) | 161.44 | 3.45 |
| Oral Bioavailability Value (OBV) | 46.79 | 1.0 (ref) |
LLC = Liquid Liposomal Curcumin (Moana Natura) · TC = Tablet Curcumin (competitor). In collaboration with Surya Research Clinics. n=20 (10 per group).
